A core facility for advanced cancer immunology and genomics services
The Computational Tumor Immunology Core (CTIC)
This study is exploring new ways to prevent cancer in people with Lynch syndrome and those with lung nodules by using advanced technology to understand how the immune system interacts with tumors, and it aims to find better treatments that could help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10906211 on NIH RePORTER |
What this research studies
The Computational Tumor Immunology Core (CTIC) provides cutting-edge computational and genomic services to support research aimed at preventing cancer in patients with Lynch syndrome and lung cancer non-solid nodules. This facility utilizes advanced techniques in tumor immunology, immunopeptidomics, and spatial genomics to analyze and interpret complex data related to cancer. By collaborating with leading experts in the field, CTIC aims to develop innovative strategies for immunoprevention and improve patient outcomes through tailored interventions. Patients may benefit from the insights gained through these analyses, which could lead to new preventive therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with Lynch syndrome or those with lung cancer non-solid nodules.
Not a fit: Patients without genetic predispositions to cancer or those not diagnosed with the specified conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new immunoprevention strategies that significantly reduce cancer risk for patients with specific genetic predispositions.
How similar studies have performed: Previous research in cancer immunology and genomics has shown promising results, indicating that similar approaches could lead to significant advancements in cancer prevention.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Lipkin, Steven M — Weill Medical Coll of Cornell Univ
- Study coordinator: Lipkin, Steven M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.